COST-EFFECTIVENESS ANALYSIS OF CANCER RISK REDUCTION STRATEGIES FOR BRCA MUTATION CARRIERS

被引:0
|
作者
Khodorovich, O. S. [1 ]
Solodkiy, V. A. [1 ]
Derkach, E., V [2 ]
机构
[1] Russian Sci Ctr Roentgenoradiol, Moscow, Russia
[2] Russian Presidential Acad Natl Econ & Publ Adm, Moscow, Russia
关键词
D O I
10.1016/j.jval.2016.09.2226
中图分类号
F [经济];
学科分类号
02 ;
摘要
PCN152
引用
收藏
页码:A736 / A736
页数:1
相关论文
共 50 条
  • [21] Cost-effectiveness of different strategies to prevent breast and ovarian cancer in German women with a BRCA 1 or 2 mutation
    Mueller, Dirk
    Danner, Marion
    Rhiem, Kerstin
    Stollenwerk, Bjoern
    Engel, Christoph
    Rasche, Linda
    Borsi, Lisa
    Schmutzler, Rita
    Stock, Stephanie
    EUROPEAN JOURNAL OF HEALTH ECONOMICS, 2018, 19 (03): : 341 - 353
  • [22] Cost-effectiveness of different strategies to prevent breast and ovarian cancer in German women with a BRCA 1 or 2 mutation
    Dirk Müller
    Marion Danner
    Kerstin Rhiem
    Björn Stollenwerk
    Christoph Engel
    Linda Rasche
    Lisa Borsi
    Rita Schmutzler
    Stephanie Stock
    The European Journal of Health Economics, 2018, 19 : 341 - 353
  • [23] Cost effectiveness of the cancer prevention program for carriers of the BRCA1/2 mutation
    de Azevedo Ramos, Marcelo Cristiano
    Azevedo Koike Folgueira, Maria Aparecida
    Maistro, Simone
    Campolina, Alessandro Goncalves
    de Soarez, Patricia Coelho
    de Bock, Geertruida Hendrika
    Dutilh Novaes, Hillegonda Maria
    Estevez Diz, Maria Del Pilar
    REVISTA DE SAUDE PUBLICA, 2018, 52
  • [24] Cost-utility analysis of risk-reducing strategies to prevent breast and ovarian cancer in BRCA-mutation carriers in Switzerland
    Bommer, Claudine
    Lupatsch, Judith
    Burki, Nicole
    Schwenkglenks, Matthias
    EUROPEAN JOURNAL OF HEALTH ECONOMICS, 2022, 23 (05): : 807 - 821
  • [25] Cost-effectiveness analysis of olaparib maintenance therapy for BRCA mutation ovarian cancer in the public sector in Malaysia
    Yong, Chee Meng
    Yehgambaram, Prathepamalar A. P.
    Lee, Shaun Wen Huey
    PLOS ONE, 2024, 19 (02):
  • [27] Cost-effectiveness of breast magnetic resonance imaging to screen BRCA1/2 mutation carriers
    Crystal, Pavel
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2006, 296 (22): : 2681 - 2682
  • [28] THE COST-EFFECTIVENESS OF GERMLINE BRCA TESTING IN PROSTATE CANCER FOLLOWED BY CASCADE TESTING OF FIRST-DEGREE RELATIVES OF MUTATION CARRIERS
    Teppala, S.
    Scuffham, P.
    Edmunds, K.
    Roberts, M.
    Fairbairn, D.
    Smith, D.
    Horvath, L.
    Tuffaha, H.
    VALUE IN HEALTH, 2024, 27 (12) : S119 - S119
  • [29] Cost-effectiveness of screening BRCA1/2 mutation carriers with breast magnetic resonance imaging
    Plevritis, Sylvia K.
    Kurian, Allison W.
    Sigal, Bronislava M.
    Daniel, Bruce L.
    Ikeda, Debra M.
    Stockdale, Frank E.
    Garber, Alan M.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2006, 295 (20): : 2374 - 2384
  • [30] Cost-Effectiveness of Bilateral Prophylactic Mastectomy in Patients at High Risk for Breast Cancer Without a Known BRCA Mutation
    Edwards, Brandy L.
    Schroen, Anneke T.
    ANNALS OF SURGICAL ONCOLOGY, 2015, 22 : 2 - 2